| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |